[Dermatomyositis: clinical study of 34 patients].
Identifieur interne : 000486 ( PubMed/Curation ); précédent : 000485; suivant : 000487[Dermatomyositis: clinical study of 34 patients].
Auteurs : M. Marschalk [Hongrie] ; G. P Nyai ; E. Ablonczy ; A. HorváthSource :
- Orvosi hetilap [ 0030-6002 ] ; 2000.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Dermatomyosite.
- traitement médicamenteux : Dermatomyosite.
- usage thérapeutique : Immunosuppresseurs.
- Adulte, Adulte d'âge moyen, Dermatomyosite, Diagnostic différentiel, Femelle, Humains, Mâle, Sujet âgé, Études rétrospectives.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Immunosuppressive Agents.
- complications : Dermatomyositis.
- diagnosis : Dermatomyositis.
- drug therapy : Dermatomyositis.
- Adult, Aged, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Retrospective Studies.
Abstract
Clinical data of 34 patients with DM, who have been treated during the years 1971 and 1998 were evaluated. 79% of the patients (27 patients) were female, 21% of them (7 patients) were male. 59% of the patients (20 pts) were between the ages of 41 and 50 years. The characteristic heliotrop rash were observed in 26 patients, Gottron's papules in 20 patients, poikiloderma in 2 patients, calcification, ulcers, Raynaud syndrome in 1 patient. 3 of the 34 patients presented with strongly itching erythematopapulosus symptoms, most prominently on the scalp. Cardiac involvement were present in 10 patients (29%), lung involvement in 8 patients (23%), gastrointestinal complaints in 11 patients, dysphagia, dysphonia in 4 patients, joint pain in 5 patients. Overlap syndrome--scleroderma-dermatomyositis, SLE-dermatomyositis--was present in 2 patients. 9 of the 34 patients (26%) suffered from malignant tumours: gastric, breast, lung, epipharynx carcinoma, malignant melanoma. 13 of the 34 patients have been treated with corticosteroids together with immunosuppressor agents, in most cases azathioprin was administered. Cyclosporin was given in 7 cases, chloroquine in 2 cases.
PubMed: 10697980
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000486
Links to Exploration step
pubmed:10697980Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Dermatomyositis: clinical study of 34 patients].</title><author><name sortKey="Marschalk, M" sort="Marschalk, M" uniqKey="Marschalk M" first="M" last="Marschalk">M. Marschalk</name><affiliation wicri:level="3"><nlm:affiliation>Bór- és Nemikórtani Klinika, Semmelweis Orvostudományi Egyetem, Budapest.</nlm:affiliation><country>Hongrie</country><placeName><settlement type="city">Budapest</settlement><region nuts="2">Hongrie centrale</region></placeName><wicri:orgArea>Bór- és Nemikórtani Klinika, Semmelweis Orvostudományi Egyetem</wicri:orgArea></affiliation></author><author><name sortKey="P Nyai, G" sort="P Nyai, G" uniqKey="P Nyai G" first="G" last="P Nyai">G. P Nyai</name></author><author><name sortKey="Ablonczy, E" sort="Ablonczy, E" uniqKey="Ablonczy E" first="E" last="Ablonczy">E. Ablonczy</name></author><author><name sortKey="Horvath, A" sort="Horvath, A" uniqKey="Horvath A" first="A" last="Horváth">A. Horváth</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2000">2000</date><idno type="RBID">pubmed:10697980</idno><idno type="pmid">10697980</idno><idno type="wicri:Area/PubMed/Corpus">000486</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000486</idno><idno type="wicri:Area/PubMed/Curation">000486</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000486</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Dermatomyositis: clinical study of 34 patients].</title><author><name sortKey="Marschalk, M" sort="Marschalk, M" uniqKey="Marschalk M" first="M" last="Marschalk">M. Marschalk</name><affiliation wicri:level="3"><nlm:affiliation>Bór- és Nemikórtani Klinika, Semmelweis Orvostudományi Egyetem, Budapest.</nlm:affiliation><country>Hongrie</country><placeName><settlement type="city">Budapest</settlement><region nuts="2">Hongrie centrale</region></placeName><wicri:orgArea>Bór- és Nemikórtani Klinika, Semmelweis Orvostudományi Egyetem</wicri:orgArea></affiliation></author><author><name sortKey="P Nyai, G" sort="P Nyai, G" uniqKey="P Nyai G" first="G" last="P Nyai">G. P Nyai</name></author><author><name sortKey="Ablonczy, E" sort="Ablonczy, E" uniqKey="Ablonczy E" first="E" last="Ablonczy">E. Ablonczy</name></author><author><name sortKey="Horvath, A" sort="Horvath, A" uniqKey="Horvath A" first="A" last="Horváth">A. Horváth</name></author></analytic><series><title level="j">Orvosi hetilap</title><idno type="ISSN">0030-6002</idno><imprint><date when="2000" type="published">2000</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Dermatomyositis (complications)</term><term>Dermatomyositis (diagnosis)</term><term>Dermatomyositis (drug therapy)</term><term>Diagnosis, Differential</term><term>Female</term><term>Humans</term><term>Immunosuppressive Agents (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Dermatomyosite ()</term><term>Dermatomyosite (diagnostic)</term><term>Dermatomyosite (traitement médicamenteux)</term><term>Diagnostic différentiel</term><term>Femelle</term><term>Humains</term><term>Immunosuppresseurs (usage thérapeutique)</term><term>Mâle</term><term>Sujet âgé</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Immunosuppressive Agents</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Dermatomyositis</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dermatomyositis</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Dermatomyosite</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dermatomyositis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Dermatomyosite</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Immunosuppresseurs</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Diagnosis, Differential</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Dermatomyosite</term><term>Diagnostic différentiel</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Sujet âgé</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Clinical data of 34 patients with DM, who have been treated during the years 1971 and 1998 were evaluated. 79% of the patients (27 patients) were female, 21% of them (7 patients) were male. 59% of the patients (20 pts) were between the ages of 41 and 50 years. The characteristic heliotrop rash were observed in 26 patients, Gottron's papules in 20 patients, poikiloderma in 2 patients, calcification, ulcers, Raynaud syndrome in 1 patient. 3 of the 34 patients presented with strongly itching erythematopapulosus symptoms, most prominently on the scalp. Cardiac involvement were present in 10 patients (29%), lung involvement in 8 patients (23%), gastrointestinal complaints in 11 patients, dysphagia, dysphonia in 4 patients, joint pain in 5 patients. Overlap syndrome--scleroderma-dermatomyositis, SLE-dermatomyositis--was present in 2 patients. 9 of the 34 patients (26%) suffered from malignant tumours: gastric, breast, lung, epipharynx carcinoma, malignant melanoma. 13 of the 34 patients have been treated with corticosteroids together with immunosuppressor agents, in most cases azathioprin was administered. Cyclosporin was given in 7 cases, chloroquine in 2 cases.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10697980</PMID><DateCompleted><Year>2000</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2009</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0030-6002</ISSN><JournalIssue CitedMedium="Print"><Volume>141</Volume><Issue>5</Issue><PubDate><Year>2000</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>Orvosi hetilap</Title><ISOAbbreviation>Orv Hetil</ISOAbbreviation></Journal><ArticleTitle>[Dermatomyositis: clinical study of 34 patients].</ArticleTitle><Pagination><MedlinePgn>225-9</MedlinePgn></Pagination><Abstract><AbstractText>Clinical data of 34 patients with DM, who have been treated during the years 1971 and 1998 were evaluated. 79% of the patients (27 patients) were female, 21% of them (7 patients) were male. 59% of the patients (20 pts) were between the ages of 41 and 50 years. The characteristic heliotrop rash were observed in 26 patients, Gottron's papules in 20 patients, poikiloderma in 2 patients, calcification, ulcers, Raynaud syndrome in 1 patient. 3 of the 34 patients presented with strongly itching erythematopapulosus symptoms, most prominently on the scalp. Cardiac involvement were present in 10 patients (29%), lung involvement in 8 patients (23%), gastrointestinal complaints in 11 patients, dysphagia, dysphonia in 4 patients, joint pain in 5 patients. Overlap syndrome--scleroderma-dermatomyositis, SLE-dermatomyositis--was present in 2 patients. 9 of the 34 patients (26%) suffered from malignant tumours: gastric, breast, lung, epipharynx carcinoma, malignant melanoma. 13 of the 34 patients have been treated with corticosteroids together with immunosuppressor agents, in most cases azathioprin was administered. Cyclosporin was given in 7 cases, chloroquine in 2 cases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marschalkó</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bór- és Nemikórtani Klinika, Semmelweis Orvostudományi Egyetem, Budapest.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pónyai</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Ablonczy</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Horváth</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>hun</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Dermatomyositis: klinikai megfigyelések 34 betegen.</VernacularTitle></Article><MedlineJournalInfo><Country>Hungary</Country><MedlineTA>Orv Hetil</MedlineTA><NlmUniqueID>0376412</NlmUniqueID><ISSNLinking>0030-6002</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003882" MajorTopicYN="Y">Dermatomyositis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>3</Month><Day>4</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>3</Month><Day>4</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10697980</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000486 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000486 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:10697980
|texte= [Dermatomyositis: clinical study of 34 patients].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:10697980" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |